Christine E Szarka , M.D.

GENERAL

Specialties:	Oncology (Board Certified in 1995) - Accepting New Patients Hematology/Oncology - Accepting New Patients

Gender: F
Years in practice: 20
Main Line HealthCare Physician

Medical School:
Medical College of Pennsylvania

Residency:
Chandler Medical Center, University of Kentucky

Fellowship:
Fox Chase Cancer Center

Primary Affiliation:  Paoli Hospital

* Members of the Main Line Health medical staff are affiliated with Bryn Mawr Hospital, Lankenau Medical Center, Paoli Hospital and Riddle Hospital.

Clinical/Dept Titles:
Attending Physician

---

PRACTICE

Practice Name:
MLHC Hem/Onc Assoc.

Locations:

Paoli Hospital Cancer Center 255 West Lancaster Avenue Paoli, PA  19301 TEL: 484.565.1600 FAX: 610.647.2006

Access Information:  Handicap Access Hours: Weekdays

Main Line Health Center 599 Arcola Road Collegeville, PA  19426 TEL: 484.565.1600 FAX: 610.647.2006

Access Information:  Handicap Access Hours: Weekdays

495 Thomas Jones Way, Suite 300 Exton, PA  19341 TEL: 484.565.1600 FAX: 610.647.2006

Access Information:  Public Transportation,Handicap Access Hours: Weekdays

Areas of Clinical Interest
Advanced treatment for all cancer diagnoses, including:
- GI Malignancies
- Breast Cancer

Statement of Practice Philosophy

To provide the highest quality treatment possible in a supportive, caring environment, utilizing the most effective and innovative therapies, while focused on each individual's special needs and goals of care.

---

PUBLICATIONS & CITATIONS

Recent Clinical Studies Published

PUBLICATIONS

Lewis, NL, Scher R, Gallo JM, Engstrom PF, Szarka CE, Litwin S, Adams AL, Kilpatrick D, Brady D, Weiner LM, Meropol NJ. Phase I and Pharmacokinetic Study of Irinotecan in Combination with Raltitrexed. Cancer Chemother. Pharmacol. 50:257-265, 2002.

Szarka CE, Hamilton TC, Klein-Szanto AJP, and Ozols RF. Chemoprevention of Ovarian Cancer. Ovarian Cancer, Oxford University Press, New York, NY pp. 153-160, 2002.

Szarka CE, Yao K-S, Pfeiffer GR, Balshem AM, Litwin S, Frucht H, Goosenberg E, Engstrom P, Clapper ML, and O’Dwyer PJ. Chronic Dosing of Oltipraz in People at Increased Risk for Colorectal Cancer. Cancer Detect. Prev. 25(4):352-361, 2001.

Sasson AR, Hoffman JP, Ross E, Meropol NJ, Szarka CE, Freedman G, Pinover W, Pingpank JF, Eisenberg BL, Trimodality Therapy for Advanced Gallbladder Cancer. Am. Surg. 67:277-284, 2001.

Hudes GR, Szarka CE, Adams A, Ranganathan S, McCauley RA, Weiner LM, Langer CJ, Litwin S, Yeslow G, Halbherr T, Qian M., and Gallo JM. Phase I Pharmacokinetic Trial of Perillyl Alcohol (NCS 641066) in Patients with Refractory Solid Malignancies Clin Cancer Res 6:3071-3080, 2000.

O’Dwyer PJ, Szarka C, Brennan JM, Laub PB, Gallo JM. Pharmacokinetics of the Chemopreventive Agent Oltipraz and of its Metabolite M3 in Human Subjects After a Single Oral Dose. Clinical Cancer Research 6(12):4692-4696, 2000.

Diefenbach MA, Szarka CE, Knowles JC, Clapper M, Miller SM, and Engstrom PE. Psychological Factors Associated with Participation and Retention in Lung Cancer Chemoprevention Trial. Cancer Detect. Prev.(under revision), 2000.

Szarka CE, Ehya H, Klein-Szanto A, Clapper M, Unger M, King E, Cecelia M, Andrew B, Gallo JM, Litwin S, Engstrom PF, Berg C. A Phase II Trial of Oltipraz as a Chemopreventive Agent for Lung Dysplasia. Proc. Am. Soc. Clin. Oncol. 19:1946, 2000.

Hudes G, Schol J, Baab J, Rogatko A, Bol C, Horak I, Langer C, Goldstein LJ, Szarka C, Meropol NJ, Weiner L. Phase I Clinical and Pharmacokinetic Trial of the Farnesyltransferase Inhibitor R115777 on a 21-day Dosing Schedule. Proc. Am.Soc. Clin. Oncol. 18:601, 1999.

 

Recent Honors, Awards, Citations

• 2010 - "Top Doc" in Oncology/Hematology, Main Line Magazine
• 2009 - "Top Doc" in Oncology/Hematology, Main Line Magazine
• 1997-2001 - Member, Pennsylvania Cancer Control Prevention & Research Advisory Board

Personal Quote

Statement of Practice Philosophy:

To provide the highest quality treatment possible in a supportive, caring environment, utilizing the most effective and innovative therapies, while focused on each individual's special needs and goals of care.

Current Memberships and Activities

American Society of Clinical OncologyAmerican Association for Cancer ResearchAmerican College of PhysiciansPennsylvania Medical Society

Membership on the medical staff of any of our hospitals does not constitute an employment or agency relationship.